Model-based iterative reconstruction (MBIR, GE Healthcare), approved by the FDA in September 2011, delivered a 74 percent mean dose reduction relative to standard-dose abdominal CT imaging and yielded improved image quality scores compared with other dose reduction techniques, according to a study published in this month's American Journal of Roentgenology.